Related Experiment Video
Updated: Jun 4, 2025
An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
Acute MeCP2 loss in adult mice reveals transcriptional and chromatin changes that precede neurological dysfunction
Sameer S Bajikar1, Jian Zhou1, Ryan O'Hara2
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX 77030, USA.
Abstract:
Mutations in the X-linked methyl-CpG-binding protein 2 (MECP2) gene cause Rett syndrome, a severe childhood neurological disorder. MeCP2 is a well-established transcriptional repressor, yet upon its loss, hundreds of genes are dysregulated in both directions. To understand what drives such dysregulation, we deleted Mecp2 in adult mice, circumventing developmental contributions and secondary pathogenesis. We performed time series transcriptional, chromatin, and phenotypic analyses of the hippocampus to determine the immediate consequences of MeCP2 loss and the cascade of pathogenesis. We find that loss of MeCP2 causes immediate and bidirectional progressive dysregulation of the transcriptome. To understand what drives gene downregulation, we profiled genome-wide histone modifications and found that a decrease in histone H3 acetylation (ac) at downregulated genes is among the earliest molecular changes occurring well before any measurable deficiencies in electrophysiology and neurological function. These data reveal a molecular cascade that drives disease independent of any developmental contributions or secondary pathogenesis.
Insights
Loss of the methyl-CpG-binding protein 2 (MECP2) gene causes immediate, bidirectional gene dysregulation. Decreased histone acetylation precedes neurological deficits in a mouse model of Rett syndrome.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mutations in the methyl-CpG-binding protein 2 (MECP2) gene are the primary cause of Rett syndrome, a severe neurodevelopmental disorder.
- MeCP2 functions as a transcriptional repressor, but its loss leads to widespread gene dysregulation in both directions.
Purpose of the Study:
- To investigate the immediate molecular and phenotypic consequences of Mecp2 loss in adult mice, independent of developmental effects.
- To elucidate the mechanisms driving gene dysregulation and pathogenesis following MeCP2 deficiency.
Main Methods:
- Time-series transcriptional profiling of the hippocampus.
- Genome-wide chromatin modification analysis, focusing on histone acetylation.
- Electrophysiological and functional neurological assessments.
Main Results:
- Loss of Mecp2 resulted in immediate and progressive bidirectional transcriptome dysregulation.
- A significant decrease in histone H3 acetylation was observed at downregulated genes, preceding functional deficits.
- These molecular changes occurred before measurable impairments in electrophysiology or neurological function.
Conclusions:
- The study reveals an early molecular cascade initiated by MeCP2 loss, characterized by reduced histone acetylation, which drives pathogenesis.
- This cascade is independent of developmental contributions or secondary pathological processes, offering insights into Rett syndrome mechanisms.
Related Concept Videos
02:23Master Transcription Regulators
01:32Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
02:25Spreading of Chromatin Modifications
Writers
The writer...